education_image.jpg

ESPE Science Symposium 2022 - Hypothalamic Dysfunction in Childhood

Aimed at paediatricians and basic researchers, to promote the dissemination of new scientific knowledge within the paediatric endocrinology community, developing an interactive network and closing the gap between scientific research and patient care.

For information and resources from a previous Science Symposium please visit here


ESPE Science Symposium 2022

7 and 8 October
Princess Máxima Center, Utrecht , The Netherlands

Hypothalamic Dysfunction in Childhood; Understanding its etiology and developing new ways to improve outcome of children with genetic or acquired causes of hypothalamic dysfunction

We are very happy to welcome you at the 2022 ESPE Science Symposium. In these 2 days we will discuss the etiology of genetic and acquired hypothalamic dysfunction in childhood, its consequences and new ways of management to improve outcome.

In addition, we will focus on building new networks and collaboration within ESPE and Europe, together with the patient organization and ENDO-ERN.

 

If you need more information or do have any questions, please contact: events@prinsesmaximacentrum.nl

Registration now open for the ESPE Science symposium!

On October 7 and 8 2022,  we will discuss the etiology of genetic and acquired hypothalamic dysfunction in childhood, its consequences and new ways of management to improve outcome.

In addition, we will focus on building new networks and collaboration within ESPE and Europe, together with the patient organizations and ENDO-ERN

There will be top experts from across Europe speaking on:

  • The hypothalamus from an evolutionary point of view, Prof Dick Swaab, NL
  • Appetite-regulating hormones in hypothalamic obesity, Dr Hoog-Wei Gan, UK
  • Congenital Disorders of Hypothalamic Dysfunction associated with Hypopituitarism.  Prof Dr Mehul Dattani, UK
  • Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction. M Tauber , France
  • Hypothalamic syndrome in craniopharyngioma, Prof dr H Mueller , Germany
  • Hypothalamic dysfunction and hypothalamitis : A Novel Autoimmune Endocrine Disease ? F Kelestimur, Turkey
  • Radiation therapy and preserving hypothalamic function; Dr G Janssens, the Netherlands
  • Neurosurgical challenges in children with hypothalamic tumors , Prof Dr E Hoving, the Netherlands
  • Hypothalamic dysfunction requires individualized treatment, Dr HM van Santen, the Netherlands
  • Treatment of hypothalamic obesity (genetic or acquired), CLI, drugs or bariatic surgery? Dr E vd Akker, the Netherlands
  • ENDO-ERN; Rare Hypothalamic Disease. Prof Nienke Biermasz, chair MTG6
  • Hypothalamic dysfunction; What do the patients need? J de Graaf , ePAG representative ENDO-ERN, MTG6

There are only limited tickets available, full=full.

CLICK HERE TO REGISTER NOW

 


Accreditation

CME Accreditation will be applied for for the ESPE Science Symposium 2022 which delegates will be able to claim back.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://www.ama-assn.org/education/ama-pra-credit-system/agreement-european-union-medical-specialties-uems.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.